HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors.

Saved in:
Bibliographic Details
Title: HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors.
Authors: Manion M; Intramural Clinical Management and Operations Branch, Office of the Clinical Director, National Institute of Allergy and Infectious Disease (NIAID), NIH, Bethesda, Maryland, United States of America., Lange CM; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.; HENYIDA LLC, Lewes, Delaware, United States of America., Ortega-Villa AM; Office of Biostatistics Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Moeser M; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America., Highbarger H; Virus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Huik K; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America., Lindo N; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America., Gonsalves C; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America., Virga J; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America., Meya DB; Department of Medicine, School of Medicine, College of Health Sciences Makerere University, Kampala, Uganda.; Department of Medicine and International Health, University of Minnesota, Minneapolis, Minnesota, United States of America., Joseph SB; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America., Boulware DR; Department of Medicine and International Health, University of Minnesota, Minneapolis, Minnesota, United States of America., Sereti I; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Disease (NIAID), NIH, Bethesda, Maryland, United States of America., Maldarelli F; Clinical Retrovirology Section, HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2026 Oct 15; Vol. 22 (10), pp. e1014697. Date of Electronic Publication: 2026 Oct 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1553-7374
DOI:10.1371/journal.ppat.1014697